ITMCTR2000003000招募中1 期
Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 60（—）
- 性别
- All
入选标准
- •1. 18 years old <= age <= 60 years old at the time of screening;
- •2. Pharyngeal swabs, alveolar lavage fluid, or sputum specimens during screening showed that 2019-nCoV virus nucleic acid test results were positive for at least two of nCov-EP, nCov-NP, and nCovORF1ab, in line with the release of a new coronavirus infection by the National Health and Medical Commission Diagnostic criteria for confirmed cases in the pneumonia diagnosis and treatment plan (trial version 5);
- •3. The investigator determined that aerosolized inhalation treatment was appropriate, and volunteered to participate in the study and signed informed consent.
排除标准
- •1. Chronic lung diseases requiring long-term oxygen therapy;
- •2. Long-term application of glucocorticoids due to underlying diseases;
- •3. Based on the researcher's judgment, previous or current diseases may affect patients' participation in the trial or influence the outcome of the study, including: malignant disease, autoimmune disease, liver and kidney disease, blood disease, neurological disease, and endocrine Disease; currently suffering from diseases that seriously affect the immune system, such as: human immunodeficiency virus (HIV) infection, or the blood system, or splenectomy, organ transplantation, etc.;
- •Subjects with the following conditions: asthma requiring daily treatment, any other chronic respiratory disease, respiratory bacterial infections such as purulent tonsillitis, acute tracheobronchitis, sinusitis, otitis media, and other respiratory diseases affecting clinical trial evaluation, Chest CT confirmed that patients with severe pulmonary interstitial lesions, bronchiectasis and other underlying lung diseases;
- •4. Breastfeeding or pregnancy test result is positive during screening or test;
- •5. Allergic constitution (persons who are allergic to more than 2 types of substances), persons who are allergic to similar drugs in the past or those who are known to be allergic to the ingredients and auxiliary materials in the test drugs;
- •6. The investigator decides that it is not in the best interest of the subject to participate in the study, or that the subject has any situation in which the protocol cannot be fully followed.
研究者
相似试验
尚未招募
3 期
Clinical Study of ''Jieyu Xingyang decoction'' in treating erectile dysfunction caused by antipsychoticErectile dysfunction due to antipsychoticsITMCTR2200005913Affiliated Brain Hospital of Guangzhou Medical University
尚未招募
不适用
Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical DataAcute Exacerbation of Chronic Obstructive Pulmonary DiseaseNCT06754865Jiangxi Qingfeng Pharmaceutical Co. Ltd.1,140
尚未招募
不适用
Clinical study for 'Yi-Qin-Fang' decoction in the treatment of uric acid nephropathy by high colon pathwayric acid nephropathyITMCTR1900002859Shenzhen Second People's Hospital
尚未招募
不适用
Prospective clinical study of Jintiange capsule in the treatment of osteosarcopeniasarcopenia and osteoporosisITMCTR2200006637The Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Unknown
不适用
A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth DiseaseHand, Foot and Mouth DiseaseNCT01182025The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine360